“I think we wanted to give the regulators, the FDA and regulators in other countries, the flexibility,” Mr. Bancel said in a March 24 interview on CNBC‘s “Squawk Box.” “You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them.”
Mr. Bancel also said he and his team at Moderna “submitted all the data that we have to give [the FDA] the best possible information to make the best possible decision.”
His comments come amid immunology experts’ ongoing debate about whether more COVID-19 boosters are necessary, as some experts say Moderna and Pfizer’s recent requests for FDA approval of second boosters puts pressure on regulatory bodies to approve additional shots before government experts can examine evidence.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
